— Know what they know.
Not Investment Advice

LCDX OTC

Caliber Imaging & Diagnostics, Inc.
1W: -83.3% 1M: -83.3% 3M: -83.3% YTD: -83.3% 1Y: +0.0% 3Y: -66.7% 5Y: -100.0%
$0.00
-0.00 (-0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 44 · $851 mcap · 988241 float · 0.062% daily turnover

Balance Sheet Trends

Total Assets
$2M -7.1% ▼
4Y CAGR: +39.3%
Total Liabilities
$15M +44.7% ▲
4Y CAGR: +11.1%
Shareholders Equity
-$12M -62.1% ▼
Cash & Investments
$787K -15.1% ▼
4Y CAGR: +127.6%
Total Debt
$12M +66.5% ▲
4Y CAGR: +29.4%
Net Debt
$11M +78.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2009FY2010FY2011FY2012FY2013
— Assets —
Cash$29K$839K$5M$926K$787K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$29K$839K$5M$926K$787K
Net Receivables$118K$328K$390K$559K$500K
Inventory$333K$357K$730K$926K$709K
Other Current Assets$0$0$0$0$0
Total Current Assets$546K$2M$6M$2M$2M
Property, Plant & Equip.$16K$17K$115K$107K$101K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$77K$299K$76K$22K$21K
Total Non-Current Assets$93K$317K$191K$130K$122K
Total Assets$640K$2M$6M$3M$2M
— Liabilities —
Accounts Payable$2M$1M$1M$956K$536K
Short-Term Debt$2M$3M$3M$379K$5M
Deferred Revenue$350K$520K$190K$323K$236K
Other Current Liabilities$0$180K$296K$635K$680K
Total Current Liabilities$7M$6M$6M$3M$7M
Long-Term Debt$2M$3M$353K$7M$7M
Other Non-Current Liab.$368K$2M$688K$505K$732K
Total Non-Current Liabilities$3M$5M$1M$7M$7M
Total Liabilities$10M$10M$7M$10M$15M
— Equity —
Common Stock$21K$23K$78K$85K$85K
Retained Earnings-$23M-$28M-$37M-$46M-$52M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$9M-$8M-$665K-$8M-$12M
Total Liabilities & Equity$640K$2M$6M$3M$2M
— Key Metrics —
Total Debt$4M$6M$4M$7M$12M
Net Debt$4M$5M-$1M$6M$11M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms